Literature DB >> 23429601

Combination therapy for the treatment of neovascular age-related macular degeneration.

Miriam Englander1, Peter K Kaiser.   

Abstract

PURPOSE OF REVIEW: To discuss the current combination treatments that involve existing as well as novel drugs that show promise for the treatment of neovascular age-related macular degeneration. RECENT
FINDINGS: Photodynamic therapy in combination with antivascular endothelial growth factor (VEGF) and steroids is currently used as a second-line therapy in patients not responding to monotherapy with anti-VEGF agents or in whom the treatment burden of monthly injections is too great. It is used as a primary therapy for idiopathic polypoidal choroidal vasculopathy. Radiation and antiplatelet-derived growth factor therapy show promising results and are currently under investigation.
SUMMARY: Using combination treatments that target other pathways involved in angiogenesis will hopefully improve on the results of current anti-VEGF agents and may result in greater visual improvement and more convenient dosing regimens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429601     DOI: 10.1097/ICU.0b013e32835f8eaa

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  6 in total

1.  Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.

Authors:  Maziar Mohammadi; Kisha Patel; Seyedeh P Alaie; Ron B Shmueli; Cagri G Besirli; Ronald G Larson; Jordan J Green
Journal:  Acta Biomater       Date:  2018-04-21       Impact factor: 8.947

Review 2.  Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies.

Authors:  Wei Wang; Miao He; Xiulan Zhang
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 3.  Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development.

Authors:  Aniruddha Agarwal; William R Rhoades; Mostafa Hanout; Mohamed Kamel Soliman; Salman Sarwar; Mohammad Ali Sadiq; Yasir Jamal Sepah; Diana V Do; Quan Dong Nguyen
Journal:  Clin Ophthalmol       Date:  2015-06-05

4.  Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up.

Authors:  Aditya Sudhalkar; Vaibhav Sethi; Priyanka Gogte; Sailaja Bondalapati; Mitali Khodani; Jay Kumar Chhablani
Journal:  Indian J Ophthalmol       Date:  2015-12       Impact factor: 1.848

5.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Authors:  Francesco Parmeggiani; Carla Enrica Gallenga; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Roberto Dell'Omo; Andrea Russo; Katia De Nadai; Donato Gemmati; Sergio D'Angelo; Elena Bolletta; Francesco Saverio Sorrentino
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

Review 6.  Epimacular brachytherapy for wet AMD: current perspectives.

Authors:  Ricardo P Casaroli-Marano; Socorro Alforja; Joan Giralt; Michel E Farah
Journal:  Clin Ophthalmol       Date:  2014-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.